Holen Sie sich die Stockscreener-App
1.38
6.12%
-0.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.47
Offen:
$1.44
24-Stunden-Volumen:
50.38M
Relative Volume:
0.96
Marktkapitalisierung:
$1.52B
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-4.60
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+20.00%
1M Leistung:
+139.21%
6M Leistung:
+81.58%
1J Leistung:
-18.82%
1-Tages-Spanne:
$1.36
$1.455
1-Wochen-Bereich:
$1.23
$1.55
52-Wochen-Spanne:
$0.3507
$1.88
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.38 | 1.61B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
156.40 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 47.28B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 43.41B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 20.69B | 16.70B | -157.13M | 1.19B | -0.155 |
|
NBIX
Neurocrine Biosciences Inc
|
139.60 | 13.78B | 2.41B | 305.80M | 492.20M | 2.95 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands (NASDAQ:TLRY) Trading Up 3.2% After Analyst Upgrade - MarketBeat
Tilray Brands (NASDAQ:TLRY) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
Tilray Brands Inc. stock trend outlook and recovery pathJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Exit strategy if you’re trapped in Tilray Brands Inc.Weekly Trend Summary & Stock Portfolio Risk Management - Newser
What the charts say about Tilray Brands Inc. today2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
What MACD and RSI say about Tilray Brands IncJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
What’s the recovery path for long term holders of Tilray Brands Inc.July 2025 Fed Impact & Verified Swing Trading Watchlist - Newser
Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.9%Should You Sell? - MarketBeat
Price action breakdown for Tilray Brands Inc.Trade Volume Summary & Long-Term Growth Portfolio Plans - Newser
Short interest data insights for Tilray Brands Inc.2025 Pullback Review & Risk Managed Trade Strategies - Newser
Does Tilray Brands Inc. qualify in momentum factor screeningChart Signals & Long-Term Investment Growth Plans - Newser
How institutional ownership impacts Tilray Brands Inc. stockMarket Performance Report & Long-Term Capital Growth Ideas - Newser
What Fibonacci levels say about Tilray Brands Inc. reboundJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Price momentum metrics for Tilray Brands Inc. explained2025 Stock Rankings & Consistent Profit Alerts - Newser
Can a trend reversal in Tilray Brands Inc. lead to recovery2025 Market Outlook & Technical Pattern Alert System - Newser
Real time scanner hits for Tilray Brands Inc. explainedEarnings Overview Report & Long Hold Capital Preservation Plans - Newser
Can Tilray Brands Inc. recover in the next quarterWeekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Tilray Brands (NASDAQ:TLRY) Trading Down 5.8%Time to Sell? - MarketBeat
If You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have Today - AOL.com
Tilray Brands: A Potential Sell-On-The-News Drop - AInvest
Tilray Brands: Momentum Now, Fundamentals Later (NASDAQ:TLRY) - Seeking Alpha
Tilray Brands (NASDAQ:TLRY) Trading Up 18.7% on Analyst Upgrade - MarketBeat
Tilray Brands (NASDAQ:TLRY) Given New $2.00 Price Target at Jefferies Financial Group - MarketBeat
Tilray Brands (NASDAQ:TLRY) Shares Gap Up After Analyst Upgrade - MarketBeat
Tilray Stock Falls 5.7% | TLRY Price Drop & Market NewsNews and Statistics - IndexBox
Investors Purchase High Volume of Call Options on Tilray Brands (NASDAQ:TLRY) - MarketBeat
Top chart patterns to watch in Tilray Brands Inc.Jobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Tilray Restores Nasdaq Compliance with $1+ Bid Price, Faces Challenging Financial Health and Regulatory Risks - AInvest
Tilray Expands Medical Cannabis Offerings in Germany with New Strains under Good Supply Brand. - AInvest
What MACD and RSI say about Tilray Brands Inc.2025 Support & Resistance & Technical Confirmation Trade Alerts - Newser
Has Tilray Brands Inc. found a price floor2025 Bull vs Bear & Smart Money Movement Tracker - Newser
Risk vs reward if holding onto Tilray Brands Inc.Gap Down & Risk Adjusted Buy and Sell Alerts - Newser
Jefferies Raises Tilray (TLRY) Price Target on Potential Cannabis Rescheduling - MSN
Why Tilray (TLRY) Shares Are Trading Lower Today - TradingView
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tilray Brands Inc-Aktie (TLRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
| Persofsky Renah | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
199,726 |
0.14%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):